Bengaluru, India

Harikrishna Tumma

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2012.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harikrishna Tumma: Innovator in Chemical Compounds

Introduction

Harikrishna Tumma is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of chemical compounds, particularly in the development of bicyclic compounds that have potential applications in medicine.

Latest Patents

Harikrishna Tumma holds a patent for a chemical compound, specifically identified as Chemical compounds—643. This invention concerns bicyclic compounds of Formula I, wherein R, R, L, L, J, Y, k, n, p, and r are defined in the description. The patent also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them, and their use in treating androgen-receptor associated conditions, particularly prostate cancer.

Career Highlights

Harikrishna Tumma is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Some of his notable coworkers include Robert Hugh Bradbury and Gregory Richard Carr, who collaborate with him on various projects within the company.

Conclusion

Harikrishna Tumma's work in chemical compounds exemplifies the innovative spirit of modern science. His contributions have the potential to impact the treatment of serious medical conditions, showcasing the importance of research and development in the pharmaceutical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…